l General Information |
Product Name | Vidofludimus |
General description | Vidofludimus is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor. |
Synonym | 2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid; 4SC-101; SC12267 |
Purity | ≥98%(HPLC) | CAS Number | 717824-30-1 |
Formula | C20H18FNO4 | Molecular Weight | 355.365 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Light green solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ~1mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Vidofludimus is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor. |
l Packaging & Storage |
Packaging | 5mg; 10mg; 25mg |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
